ID   B16-F10.9.neo
AC   CVCL_E3VR
SY   F10.9.neo; F10.9-Neo
RX   PubMed=2639904;
CC   Characteristics: Control cell line for B16-F10.9.K1 (Cellosaurus=CVCL_E3VS), B16-F10.9.K13 (Cellosaurus=CVCL_E3VT), B16-F10.9.K17 (Cellosaurus=CVCL_E3VU) and B16-F10.9.KG1 (Cellosaurus=CVCL_E3VV) (PubMed=2639904).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E3VQ ! B16-F10.9
SX   Male
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=2639904; DOI=10.1111/j.1744-313x.1989.tb00475.x;
RA   Porgador A., Feldman M., Eisenbach L.;
RT   "H-2Kb transfection of B16 melanoma cells results in reduced
RT   tumourigenicity and metastatic competence.";
RL   J. Immunogenet. 16:291-303(1989).
//